Optical Express Group claims good patient outcomes

Article

Recent research by the Optical Express Group says it has revealed that of 32,000 clients surveyed following treatment in 2009, 89 per cent achieved 20/16 vision or better.

Recent research by the Optical Express Group says it has revealed that of 32,000 clients surveyed following treatment in 2009, 89 per cent achieved 20/16 vision or better. The business has also recently made a $12 million investment installing iFS 150 femtosecond laser systems in all its 44 treatment clinics in the UK.

Commenting on the trend towards better than 20/20 outcomes Dr Steve Schallhorn, Medical Director and Chair of the International Medical Advisory Board for Optical Express said: “What we have reported is that our highly skilled surgeons using the very latest advancements in LASIK technology, consistently results in most patients achieving better than 20/20 unaided vision. These outcomes are phenomenal and testament to the medical and surgical care provided by Optical Express. It is also setting a new world-wide standard for laser eye surgery procedure outcomes.

“From a very early stage, Optical Express decided to lead from the front by advancing the frontiers of laser eye surgery. Together with the greatest experience in ophthalmology, our International Medical Advisory Board is second to none and is driving up standards to deliver safe and effective eye surgery with high levels of patient satisfaction.

“We continue to have very high levels of satisfaction among our patients. This is evidenced through our growth over the last year, during a time of deep economic turmoil.”

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.